You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. New heterocyclic inhibitors of filoviruses

    SBC: MICROBIOTIX, INC.            Topic: H

    DESCRIPTION provided by applicant Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral i ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. New small molecule inhibitors of arenaviruses

    SBC: MICROBIOTIX, INC.            Topic: R

    DESCRIPTION provided by applicant Lassa fever virus LASV and Machupo virus MACV are hemorrhagic fever arenaviruses which are classified as Category A Agents Currently there are no licensed LASV or MACV vaccines and LASV MACV therapy is limited to use of the nucleoside analog ribavirin which is only partially effective and associated with significant side effects The impact of arenavirus ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. STTR Phase I: Robotic Leg Advancement Device

    SBC: AndrosRobotics LLC            Topic: EI

    This Small Business Technology Transfer Research (STTR) Phase I project seeks to develop a novel, intelligent device for automation of gait training in the neurological patient population undergoing physical therapy and rehabilitation. The objective of this project is the creation of a physically simple robotic system, which uses a sophisticated control system to intelligently cooperate with the p ...

    STTR Phase I 2014 National Science Foundation
  5. STTR Phase I: Software-Based Building Airflow Analysis Tool for Enabling HVAC Energy Use Savings in Commercial Buildings

    SBC: Aeolus Building Efficiency Inc            Topic: BC

    This Small Business Technology Transfer (STTR) Phase I project will establish proof of concept for a unique, software-based Building Airflow Analysis Tool for measuring and optimizing airflow rates in commercial buildings. Using the existing Building Automation System (BAS), room temperature responses to controlled perturbations of airflow rates are used with a physics-based room thermal model and ...

    STTR Phase I 2014 National Science Foundation
  6. STTR Phase I: Silver Replacement for Conductive Inks

    SBC: Microreactor Solutions LLC            Topic: NM

    This Small Business Innovation Research (SBIR) Phase I project will develop new materials to replace silver in conductive ink applications. Current silver replacement materials all have significant drawbacks making them unsuitable for use in many industries which would benefit from these cost savings. The project will utilize advanced thin film nanocoatings to produce silver replacement materials ...

    STTR Phase I 2014 National Science Foundation
  7. Multiferroic Materials for RF Applications

    SBC: WINCHESTER TECHNOLOGIES LLC            Topic: ST13B003

    Voltage tunable multiferroic materials with strong magnetoelectric coupling provide a unique approach to compact, lightweight and power efficient tunable RF/microwave multiferroic components, such as tunable inductors, filters, phase shifters, etc. The tu

    STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency
  8. Wideband Tunable Multiferroic Electronics for Advanced RF Systems (1000-277)

    SBC: SI2 TECHNOLOGIES, INC            Topic: ST13B003

    SI2 Technologies proposes to design, model, fabricate and transition wideband tunable multiferroic electronics for advanced RF systems including adaptive Radar, software defined radios and other electronic warfare (EW) applications. Combining novel nanost

    STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency
  9. Development of small near-infrared laser system capable of improving immune respo

    SBC: SEMINEX CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): The broad and long-term objective of this project is to amplify the effectiveness of vaccines without the use of chemical or biological adjuvants. We will address this objective by demonstrating the feasibility for small laser- based devices to enhance responses to intradermal vaccination. A number of investigators have shown that a promising new way to make va ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Therapeutic Utility of renalase and renalase peptides in cisplatin-mediated renal

    SBC: BESSOR PHARMA, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): Cisplatin is a cornerstone therapy for a number of cancers including testicular, bladder, ovarian and lung. It is also used to treat cancers in children. In all cases there is a high incidence of acute kidney injury (AKI) that can also lead to later stage kidney damage. This risk limits its use. We have found in pilot studies that renalase, or peptide fragment ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government